These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35037854)

  • 21. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease.
    Timmons JA; Atherton PJ; Larsson O; Sood S; Blokhin IO; Brogan RJ; Volmar CH; Josse AR; Slentz C; Wahlestedt C; Phillips SM; Phillips BE; Gallagher IJ; Kraus WE
    Nucleic Acids Res; 2018 Sep; 46(15):7772-7792. PubMed ID: 29986096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
    Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
    PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing drugs targeting metabolic diseases for cancer therapeutics.
    Pillai U J; Ray A; Maan M; Dutta M
    Drug Discov Today; 2023 Sep; 28(9):103684. PubMed ID: 37379903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure.
    Marcheva B; Weidemann BJ; Taguchi A; Perelis M; Ramsey KM; Newman MV; Kobayashi Y; Omura C; Manning Fox JE; Lin H; Macdonald PE; Bass J
    Elife; 2022 Feb; 11():. PubMed ID: 35188462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    Matone A; Derlindati E; Marchetti L; Spigoni V; Dei Cas A; Montanini B; Ardigò D; Zavaroni I; Priami C; Bonadonna RC
    PLoS One; 2017; 12(8):e0182559. PubMed ID: 28777829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of the human hepatic and adipose tissue transcriptomes during LPS-induced inflammation leads to the identification of differential biological pathways and candidate biomarkers.
    Szalowska E; Dijkstra M; Elferink MG; Weening D; de Vries M; Bruinenberg M; Hoek A; Roelofsen H; Groothuis GM; Vonk RJ
    BMC Med Genomics; 2011 Oct; 4():71. PubMed ID: 21978410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repurposed drugs in metabolic disorders.
    Finsterer J; Frank M
    Curr Top Med Chem; 2013; 13(18):2386-94. PubMed ID: 24059459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational drug repositioning of atorvastatin for ulcerative colitis.
    Bai L; Scott MKD; Steinberg E; Kalesinskas L; Habtezion A; Shah NH; Khatri P
    J Am Med Inform Assoc; 2021 Oct; 28(11):2325-2335. PubMed ID: 34529084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights Into Drug Repurposing for COVID-19 Using Deep Learning.
    Lee CY; Chen YP
    IEEE Trans Neural Netw Learn Syst; 2021 Nov; 32(11):4770-4780. PubMed ID: 34546931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes.
    Chen Z; Yu H; Shi X; Warren CR; Lotta LA; Friesen M; Meissner TB; Langenberg C; Wabitsch M; Wareham N; Benson MD; Gerszten RE; Cowan CA
    Circ Res; 2020 Jan; 126(3):330-346. PubMed ID: 31739742
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
    Johansen T; Laurino C; Barreca A; Malmlöf K
    Growth Horm IGF Res; 2005 Feb; 15(1):55-63. PubMed ID: 15701573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The crucial role and mechanism of insulin resistance in metabolic disease.
    Zhao X; An X; Yang C; Sun W; Ji H; Lian F
    Front Endocrinol (Lausanne); 2023; 14():1149239. PubMed ID: 37056675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repurposing for metabolic disorders: Scientific, technological and economic issues.
    Bui NL; Hoang DA; Ho QA; Nguyen Thi TN; Singh V; Chu DT
    Prog Mol Biol Transl Sci; 2024; 207():321-336. PubMed ID: 38942542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.